Alternative Treatments: Identifying Options After FDA Reclassification of Specific Peptides Bergen Total Health FDA Adds Several Peptides to Category 2 Bulks List, Restricting Them From Compounding Restore Health Consulting The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York A Turning Point for Peptides? What RFK Jr.'s Announcement Could Mean for the Future of Wellness and Longevity Skytale Group FDA has removed certain bulk drug substances that were placed on the category two list and has announced it will consult the Pharmacy Compounding Advisory Committee (PCAC) for potential future inclusion of